The role of thymidylate synthase levels in the prognosis and the treatment of patients with colorectal cancer

Anticancer Research

Volumn 18, Issue 3 A, 1998, Pages 1515-1520

  Sanguedolce, Rosario ^a   Vultaggio, Giuseppe ^a   Sanguedolce, Francesco ^a   Modica, Giuseppe ^b   Li Volsi, Francesco ^b   Diana, Giuseppe ^c   Guereio, Giovanni ^c   Bellanca, Lina ^a   Rausa, Luciano ^d,e  

^a Istituto di Farmacologia   (Italy)

^b Ist Clin e Fisiopatologica Chir   (Italy)

^c Istituto di Clinica Medica   (Italy)

^d Istituto di Oncologia   (Italy)

^e Policlinico   (Italy)

Author keywords

5 Fluorouracil; Colorectal cancer; Thymidylate synthase

Indexed keywords

THYMIDYLATE SYNTHASE;

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; COLON CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER;

EID: 0031856639     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Sanguedolce R, Brumarescu 1, Dardanoni G et al: Thymidylate synthase level and DNA-ploidy pattern as possible prognostic factors in human colorectal cancer: a preliminary study: Anticancer Res 15: 901-906,1995.
2. Boring CC, Squires TS, Tong T: Cancer Statistics. Cancer Journal for Clinicans 44: 7-26, 1994.
3. Moertel CG: Chemotherapy for colorectal cancer. New England J Med 330: 1136-1143, 1994.
4. Dukes CE: The classification of cancer of the rectum. J Pathol 35: 323, 1932.
5. Broders AC: The grading of carcinoma. Minn Med 8: 726,1925.
6. Levin P, Mittelman A, Douglass H et al: Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group Report. Cancer (Phila) 46: 1536-43, 1980.
7. Pinedo HM and Peters GJ: 5-Fluorouracil: biochemistry and Pharmacology. J Clin One 6: 1653-1664,1988.
8. Danenberg PV: Thymidylate Synthase: a target enzyme in cancer chemotherapy. Biochem Biophis Acta 473: 73-92, 1977.
9. Santi DV, Langenbach RJ and Heidelberger C: Mechanism of interaction of Thymidylate Synthase with 5-Fluorodeoxyuridylate. Biochemistry 13: 471-80, 1974.
10. Danenberg PV, Langenbach RJ and Heidelberger C: Structure of reversible and irreversible complexes of Thymidylate Synthetase and fluoropyrimidine nucleotides. Biochemistry 13: 926-33, 1974.
11. Glazer PI and Pealer AL.: The effects of 5-Fluorouracil on the synthesis of nuclear RNA in L1210 cells in vitro; Mol Pharmacol 16: 270-77, 1979.
12. Glazer DW and Hartmann KD: The effect of 5-Fluorouracil on the synthesis and methylation of low molecular weight nuclear RNA in L1210 cells in vitro. Mol Pharmacol 17: 245-249,1979.
13. Kufe DW, Major PP, Egan EM and Loh E: 5-Fluoro-2-deoxyuridyne incorporation into L1210 DNA. J Biol Chem 256: 8885-8888, 1981.
14. Danenberg PV, Heidelberger C, Mulkins M er al: The incorporation of 5-Fluoro-2-deoxyuridine into DNA of mammalian tumor cells. Biochem Biophys Res Commun 102: 654-58, 1981.
15. Shuetz JD, Wallace Hj and Diasio RB: 5-Fluorouracil incorporation into DNA of CF-1 mouse bone marrow cells as a possible mechanism of toxicity. Cancer Res 44: 1358-1363, 1984.
16. Peters GJ, Laurence E, Leyva A et al: Tissue homogenization using a microdismembrator for the measurement of enzyme activities. Clin Chim Acta 158: 193-98, 1986.
17. Moran RG, Spears CP and Heidelberger C: Biochemical determinants of tumor sensitivity of 5-Fluorouracil. Ultrasensitive methods for the determination of 5-Fluoro-2-deoxyuridilate. 2-deoxyuridilate and Thymidilate sinthetase. Proc Natl Acad Sci USA 76: 1456, 1979.
18. Wilcoxon F: Individual comparison by ranking methods. Biometrics Boll 1: 80-83, 1945.
19. Kruskal WH and Wallis WA: Use of the ranks in one-criterion variance analysis. J Am Statis Ass 47: 583-621, 1952.
20. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457-81, 1958.
21. Peters GJ, van Groningen CJ, Laurence E et al: Thymidylate synthase from untreated human colorectal cancer and colonie mucosa: enzyme activity and inhibition by fluoro-2-deoxy-uridine-5-monophosphate. Eur J Cancer 27: 263-7, 1991.
22. Wolberg WH and Morin J: Thymidylate synthetase activity and fluorouracil sensitivity of human colonie cancer and normal mucosal tissue preparations: Cancer 47: 1313-17, 1981.
23. DE Vita VT, Hellman JS (EDS): Cancer, principles and practise of oncology: Philadelphia; JB Lippincot Cp 1982; pp 868-870.
24. Philipps RKS, Hittinger R, Blesssowsky L et al: Large bowel cancer: surgical pathology and its relation to survival. British J Surgery 1984; 71; 604.
25. Astler VB and Coller FA: The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846-52,1954.
26. Spratt JS and Spjt Hj: Prevalence and prognosis of individual clinical and pathologic variables associates with colorectal carcinoma. Cancer 20: 1976-1985, 1967.
27. Rustum YM, Madajewicz MD, Campbell J et al: Clinical, biochemical pharmacology of 5-formyltetrahydrofolate in combination with 5-fluorouracil in patients with advanced colorectal carcinoma: corraletion with clinical response. Proceedings of a symposium held on March 12, 1984, at New York City. Sponsored by Roswell Park Memorial Institute, Buffalo. Advances in Cancer Chemother, 1984.
28. Peters GJ, van der Wilt CL, van Triest B et al: Thymidylate synthase and drug resistance. Eur J Cancer 31 A: 1299-1305,1995.
29. Johnston PG, Lenz HJ, Leichman CG et al: Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. Cancer Res 55: 1407-1421, 1995.
30. Sobrero A, Aschele C, Guglielmi A et al: Resistance to 5Fu and fluoro-2-deoxyuridine: mechanism and clinical implications. J Chemotherapy 2: 12-16, 1990.
31. Johnston PG, Fisher ER, Allegra CJ et al: The role of thymidylate synthase expression in prognosis and outcome of adjuvant chemotherapy in patients with rectal cancer. J Clinical Oncol 12: 2640-2647, 1994.
32. Lenz HJ, Liechman CG, Danenberg KD et al: mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clinical Oncol 14: 176-182, 1995.
33. Findlay MPN, Cunningham D, Aherne GW et al: Lack of correlation between thymidylate synthase levels in primary colorectal tumors and subsequent response to chemotherapy. British J Cancer: 75 (6): 903-909, 1997.
34. Berger S, Barbour K W and Berger F: A naturally occuring variation in Thymidylate synthase structure is associated with a reduced response to 5-Fluoro-2'-deoxyuridine in a human colon tumor cell line. Mol Pharmacol 31: 480484, 1988.
35. Barbour KW, Berger S, Berger F et al: A naturally occurring Tyrosine to Histidine replacement at residue 33 of human Thymidylate Synthase confers resistance to 5-Fluoro-2'-deoxyuridine in mammalian and bacterial cells. Mol Pharmacol 42: 242-248, 1995.
36. Houghton PJ, Rahman A, Will CL et al: Mutation of TS gene of human adenocarcinoma cells cause a TS-negative phenotype that can be attenuated by exogenous folates. Cancer Res 52: 558, 1992.